Nghi Co Nguyen, MD, PHD | |
5323 Harry Hines Blvd, Dallas, TX 75390-7201 | |
(214) 648-7776 | |
Not Available |
Full Name | Nghi Co Nguyen |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 24 Years |
Location | 5323 Harry Hines Blvd, Dallas, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295931285 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | T1490 (Texas) | Secondary |
207U00000X | Nuclear Medicine | T1490 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain's hemispheres to "sync" with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young age.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
"Decision aids" in the form of informational brochures help get patients talking about their anesthesia and pain relief options, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. Shared decision making is critical to a more patient-centered process, as well as helping patients take an active role in their medical decisions.
› Verified 2 days ago
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain's hemispheres to "sync" with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young age.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
"Decision aids" in the form of informational brochures help get patients talking about their anesthesia and pain relief options, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. Shared decision making is critical to a more patient-centered process, as well as helping patients take an active role in their medical decisions.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Nghi Co Nguyen, MD, PHD Po Box 845347, Dallas, TX 75284-5347 Ph: () - | Nghi Co Nguyen, MD, PHD 5323 Harry Hines Blvd, Dallas, TX 75390-7201 Ph: (214) 648-7776 |
News Archive
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain's hemispheres to "sync" with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young age.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
"Decision aids" in the form of informational brochures help get patients talking about their anesthesia and pain relief options, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. Shared decision making is critical to a more patient-centered process, as well as helping patients take an active role in their medical decisions.
› Verified 2 days ago